Cantor Fitzgerald Upgrades Merus Labs International (TSE:MSL) to Strong-Buy

Merus Labs International (TSE:MSL) (NASDAQ:MSLI) was upgraded by research analysts at Cantor Fitzgerald to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

Merus Labs International Price Performance

Merus Labs International has a 52 week low of C$0.95 and a 52 week high of C$1.76.

Merus Labs International Company Profile

Merus Labs International Inc is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company’s products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin. Elantan are tablets or capsules that belong to a group of medicines called organic nitrates. Isoket belongs to a group of medicines called organic nitrates. Deponit belongs to a group of medicines called nitrates.